{"organizations": [], "uuid": "5df251ba3820a0525f58156202d921ab383b01ea", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/04/24/the-associated-press-edwards-lifesciences-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Edwards Lifesciences: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T00:30:00.000+03:00", "replies_count": 0, "uuid": "5df251ba3820a0525f58156202d921ab383b01ea"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/04/24/the-associated-press-edwards-lifesciences-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Edwards Lifesciences: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [{"name": "edwards lifesciences", "sentiment": "negative"}], "locations": [{"name": "calif.", "sentiment": "none"}, {"name": "irvine", "sentiment": "none"}, {"name": "irvine", "sentiment": "none"}], "organizations": [{"name": "edwards lifesciences corp.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "edwards lifesciences", "sentiment": "none"}, {"name": "standard & poor", "sentiment": "none"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported first-quarter earnings of $206.6 million.\nOn a per-share basis, the Irvine, California-based company said it had net income of 96 cents. Earnings, adjusted for non-recurring costs, were $1.22 per share.\nThe results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.10 per share.\nThe medical device maker posted revenue of $894.8 million in the period, missing Street forecasts. Eight analysts surveyed by Zacks expected $930.2 million.\nFor the current quarter ending in July, Edwards Lifesciences expects its per-share earnings to range from $1.05 to $1.15.\nThe company said it expects revenue in the range of $950 million to $1 billion for the fiscal second quarter.\nEdwards Lifesciences expects full-year earnings in the range of $4.50 to $4.70 per share, with revenue ranging from $3.5 billion to $3.9 billion.\nEdwards Lifesciences shares have increased 19 percent since the beginning of the year, while the Standard & Poor's 500 index has decreased 1.5 percent. In the final minutes of trading on Tuesday, shares hit $134.67, a climb of 37 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW", "external_links": [], "published": "2018-04-25T00:30:00.000+03:00", "crawled": "2018-04-25T06:55:54.012+03:00", "highlightTitle": ""}